4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-104437
Chief Technical Officer sold 2,815 shares at $115.01 ($323,750)
- Chief Technical Officer acquired 2,815 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shulman Joseph Chief Technical Officer | 2025-10-28 | Option exercise 10b5-1 | +2,094 | $27.35 | $57,271 | 10,603 | D |
| Shulman Joseph Chief Technical Officer | 2025-10-28 | Option exercise 10b5-1 | +721 | $30.66 | $22,106 | 11,324 | D |
| Shulman Joseph Chief Technical Officer | 2025-10-28 | Sale 10b5-1 | −2,815 | $115.01 | $323,750 | 8,509 | D |
| Derivatives | |||||||
| Shulman Joseph Chief Technical Officer | 2025-10-28 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −2,094 | 12,563 | D | ||
| Shulman Joseph Chief Technical Officer | 2025-10-28 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −721 | 9,748 | D | ||
| Open-market sales · 2,815 sh · avg $115.01 · $323,750 | |||||||
Loading xslF345X05/tm2529785-1_4seq1.xml…